Biofrontera announces 100 RhodoLED XL machines placed in U.S. market

Biofrontera announced that the 100th commercial RhodoLED XL Lamp has now been installed in the US market. The RhodoLED XL was approved by the FDA for use in combination with Ameluz in 2022 and was launched in June of this year. Since then, it has seen rapid adoption by offices who had previously used Ameluz and those who are new to the product, with 100 now being installed since launch. The main difference between the company’s existing BF-RhodoLED lamp and the new RhodoLED XL is the number of LED panels which allows a larger surface area to be illuminated during a single PDT treatment with Ameluz.